Last month, in an article for Mayo Clinic Proceedings,
a group of 118 distinguished doctors united to question the pricing of
cancer drugs, which is "unsustainable," and to call for a new pricing
method. As this 60 Minutes report reveals,
the drug companies set the price of cancer drugs as high as they can.
And because of their market power, cancer drug prices have risen an
average of $8,500 a year for the last 15 years, a five to ten-fold
increase in the price of new cancer drugs over that period.
One in three Americans will have some form of cancer. And, even with insurance, they typically will end up bearing 20 to 30 percent of the cost of their cancer drugs. Insurers have no ability to rein in prices so insurers simply shift more drug costs to their members. People who need a new cancer drug easily could end up with out-of-pocket annual costs of $30,000 just for their cancer medication. Worse still, they might have to forego needed treatment. In 2014, the least expensive new cancer drug approved cost more than $120,000 a year.
American households have an average gross income of $52,000. And half of people over 65 have incomes under $23,500. Most Americans will need to sell assets or take out loans to pay for the drugs.
Not surprisingly, as many as one in five cancer patients today are not taking their cancer treatments or taking less than the amount they need. They and their families are suffering and some are needlessly dying. The doctors argue that something has to change.
The doctors offer several possible solutions, including Medicare drug price negotiation, which is the top policy priority for Americans. They also suggest legislation that would prevent pharmaceutical companies from paying generic drug companies to delay putting generic drugs in the market at lower prices and/or that would allow Americans to import drugs from abroad at lower prices. Click here to read their other proposed solutions.
Read more: Doctors Say Cancer Drug Prices Unaffordable | Diane Archer
One in three Americans will have some form of cancer. And, even with insurance, they typically will end up bearing 20 to 30 percent of the cost of their cancer drugs. Insurers have no ability to rein in prices so insurers simply shift more drug costs to their members. People who need a new cancer drug easily could end up with out-of-pocket annual costs of $30,000 just for their cancer medication. Worse still, they might have to forego needed treatment. In 2014, the least expensive new cancer drug approved cost more than $120,000 a year.
American households have an average gross income of $52,000. And half of people over 65 have incomes under $23,500. Most Americans will need to sell assets or take out loans to pay for the drugs.
Not surprisingly, as many as one in five cancer patients today are not taking their cancer treatments or taking less than the amount they need. They and their families are suffering and some are needlessly dying. The doctors argue that something has to change.
The doctors offer several possible solutions, including Medicare drug price negotiation, which is the top policy priority for Americans. They also suggest legislation that would prevent pharmaceutical companies from paying generic drug companies to delay putting generic drugs in the market at lower prices and/or that would allow Americans to import drugs from abroad at lower prices. Click here to read their other proposed solutions.
Read more: Doctors Say Cancer Drug Prices Unaffordable | Diane Archer
No comments:
Post a Comment